US equities |
SPCX $147.79 ▲+0.00% MU $896.07 ▲+0.00% TSLA $373.71 ▲+0.00% NVDA $216.47 ▲+0.00% SNDK $1,365.38 ▲+0.00% SKHY $139.79 ▲+0.00% INTC $91.69 ▲+0.00% AMD $534.74 ▲+0.00%
FinancialContent

Articles published by SOD SCIENCES INC.

News headline image
SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
From SOD SCIENCES INC.
Via ACCESS Newswire
Tickers VVOS